GH
Guardant HealthBNasdaq / Health Care Equipment & Services
Last Price
At close
2026-06-02
Current thesis
Successful scaling of commercial tests and favorable reimbursement lifts revenue and margins toward analyst highs.
Posture
Constructive
Lead driver
Momentum
What changed
2 setup hits (3d) with net bullish as of 2026-06-02.
What can break
Adverse reimbursement decisions limiting commercial uptake
Momentum
95
Value
36
Sentiment
37
Setup hits (3d)
2 · Net Bullish
AI TargetsBase $113.84 · Bull $175.00 · Bear $55.00
Data freshness
Prices
As of 2026-06-02
Fundamentals
As of 2026-06-01 • Vendor: Data Vendor v1
Scores
As of 2026-06-02 • Model: HYBRID_IC_RP
AI Memo
As of 2026-02-20 • Model: RankAlpha Sentiment AI
Investment thesisAs of 2026-06-02
Investment thesis
As of 2026-06-02
Supporting evidence
What
Grade B · Constructive
Confidence Medium · Net Bullish
Target $132.57
Why
Momentum95 · Δ7d +13.5
Value36 · Δ7d -0.0
Sentiment37 · Δ7d -4.9
So what
Strength-led posture (Net Bullish). Favor watchlist adds and disciplined entries.
Lead driver: Momentum · See technicals
Momentum
95
34% active weight
Current posture
7d trendFlat
Δ7d
+13.5
Δ21d
+49.8
Value
36
32% active weight
Current posture
7d trendFlat
Δ7d
-0.0
Δ21d
+0.1
Sentiment
37
33% active weight
Current posture
7d trendSoftening
Δ7d
-4.9
Δ21d
-22.1
Why this grade
Composite grade B. Momentum 95.5 / Value 36.4 / Sentiment 36.5
Fundamentals (TTM)As of 2026-06-01
Fundamentals (TTM)
As of 2026-06-01
Market Cap
$17.12B
Beta
1.64
Shares Out
128.84M
P/E (TTM) · Derived
-40.0
P/S (TTM)
14.54
P/FCF (TTM) · Derived
-62.92
Rev YoY
+38.5%
EPS YoY
+15.2%
Gross Margin
+63.8%
Op Margin
-48.1%
Net Debt
$302.57M
Current Ratio
3.50
As of 2026-06-02 • Updated nightlySource: Internal modelMethodology